MicroRNA Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium

Single nucleotide polymorphisms (SNP) in microRNA-related genes have been associated with epithelial ovarian cancer (EOC) risk in two reports, yet associated alleles may be inconsistent across studies. We conducted a pooled analysis of previously identified SNPs by combining genotype data from 3,973...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2011-08, Vol.20 (8), p.1793-1797
Hauptverfasser:	PERMUTH-WEY, Jennifer, ZHIHUA CHEN, FENSTERMACHER, David, FRIDLEY, Brooke L, GARCIA-CLOSAS, Montserrat, GAYTHER, Simon A, GENTRY-MAHARAJ, Aleksandra, GONZALEZ-BOSQUET, Jesus, IVERSEN, Edwin, JIM, Heather, MCLAUGHLIN, John, MENON, Usha, TSAI, Ya-Yu, NAROD, Steven A, PHELAN, Catherine M, RAMUS, Susan J, RISCH, Harvey, HONGLIN SONG, SUTPHEN, Rebecca, TERRY, Kathryn L, TYRE, Jonathan, VIERKANT, Robert A, WENTZENSEN, Nicolas, LIN, Hui-Yi, LANCASTER, Johnathan M, CHENG, Jin Q, BERCHUCK, Andrew, PHAROAH, Paul D. P, SCHILDKRAUT, Joellen M, GOODE, Ellen L, SELLERS, Thomas A, CHEN, Y. Ann, BARN HOLTZ-SLOAN, Jill, BIRRER, Michael J, CHANOCK, Stephen J, CRAMER, Daniel W, CUNNINGHAM, Julie M
Format:	Artikel
Sprache:	eng
Schlagworte:	Binding Sites Bioindicators Biological and medical sciences biomarkers Calcium channels (voltage-gated) Cancer Carcinoma, Ovarian Epithelial Data processing Female Female genital diseases Genetic Predisposition to Disease Genotype Genotypes Gynecology. Andrology. Obstetrics Humans Interleukin 1 Invasiveness K-Ras protein Medical sciences MicroRNAs - genetics miRNA Neoplasms, Glandular and Epithelial - genetics Ovarian cancer Ovarian carcinoma Ovarian Neoplasms - genetics Polymorphism, Single Nucleotide Prevention Risk Factors Single-nucleotide polymorphism Stratification Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!